Pre-clinical data on HOOKIPA’s arenaviral immunotherapeutic in melanoma published in Nature Communications

NEXT STORY
Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
PREV STORY
Global $66.59 Billion Proteomics Markets, Competition, Forecast & Opportunities, 2026F
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics To Present Step-1 Results of Phase 3 Clinical Trial of Tedopi® ‘Atalante 1’ in Non-Small Cell Lung Cancer at the European Society for Medical Oncology (ESMO) Virtual Congress 2020

author_avatar
NASDAQ Market News

First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion

author_avatar
NASDAQ Market News

Cempra Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Current cash balance now expected to fund operations through 2017 Management to host webcast and ...

author_avatar
NASDAQ Market News